scholarly journals Mapping the road to elimination: a 5-year evaluation of implementation strategies associated with hepatitis C treatment in the veterans health administration

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Vera Yakovchenko ◽  
Timothy R. Morgan ◽  
Matthew J. Chinman ◽  
Byron J. Powell ◽  
Rachel Gonzalez ◽  
...  

Abstract Background While few countries and healthcare systems are on track to meet the World Health Organization’s hepatitis C virus (HCV) elimination goals, the US Veterans Health Administration (VHA) has been a leader in these efforts. We aimed to determine which implementation strategies were associated with successful national viral elimination implementation within the VHA. Methods We conducted a five-year, longitudinal cohort study of the VHA Hepatic Innovation Team (HIT) Collaborative between October 2015 and September 2019. Participants from 130 VHA medical centers treating HCV were sent annual electronic surveys about their use of 73 implementation strategies, organized into nine clusters as described by the Expert Recommendations for Implementing Change taxonomy. Descriptive and nonparametric analyses assessed strategy use over time, strategy attribution to the HIT, and strategy associations with site HCV treatment volume and rate of adoption, following the Theory of Diffusion of Innovations. Results Between 58 and 109 medical centers provided responses in each year, including 127 (98%) responding at least once, and 54 (42%) responding in all four implementation years. A median of 13–27 strategies were endorsed per year, and 8–36 individual strategies were significantly associated with treatment volume per year. Data warehousing, tailoring, and patient-facing strategies were most commonly endorsed. One strategy—“identify early adopters to learn from their experiences”—was significantly associated with HCV treatment volume in each year. Peak implementation year was associated with revising professional roles, providing local technical assistance, using data warehousing (i.e., dashboard population management), and identifying and preparing champions. Many of the strategies were driven by a national learning collaborative, which was instrumental in successful HCV elimination. Conclusions VHA’s tremendous success in rapidly treating nearly all Veterans with HCV can provide a roadmap for other HCV elimination initiatives.

2017 ◽  
Vol 40 (7) ◽  
pp. 687-711
Author(s):  
Edward Alan Miller ◽  
Stefanie Gidmark ◽  
Emily Gadbois ◽  
James L. Rudolph ◽  
Orna Intrator

Veterans enrolled within the Veterans Health Administration (VHA) of the U.S. Department of Veterans Affairs (VA) may receive nursing home (NH) care in VHA-operated Community Living Centers (CLCs), State Veterans Homes (SVHs), or community NHs, which may or may not be under contract with the VHA. This study examined VHA staff perceptions of how Veterans’ eligibility for VA and other payment impacts NH referrals within VA Medical Centers (VAMCs). Thirty-five semistructured interviews were performed with discharge planning and contracting staff from 12 VAMCs from around the country. VA staff highlights the preeminent role that VA priority status played in determining placement in VA-paid NH care. VHA staff reported that Veterans’ placement in a CLC, community NH, or SVH was contingent, in part, on potential payment source (VA, Medicare, Medicaid, and other) and anticipated length of stay. They also reported that variation in Veteran referral to VA-paid NH care across VAMCs derived, in part, from differences in local and regional policies and markets. Implications for NH referral within the VHA are drawn.


2016 ◽  
Vol 150 (4) ◽  
pp. S1158
Author(s):  
Shari S. Rogal ◽  
Vera Yakovchenko ◽  
Rachel Gonzalez ◽  
Whitney Rockefeller ◽  
William Lukesh ◽  
...  

2015 ◽  
Vol 36 (6) ◽  
pp. 710-716 ◽  
Author(s):  
Molly J. Horstman ◽  
Yu-Fang Li ◽  
Peter L. Almenoff ◽  
Ron W. Freyberg ◽  
Barbara W. Trautner

OBJECTIVETo examine the impact on infection rates and hospital rank for catheter-associated urinary tract infection (CAUTI), central line-associated bloodstream infection (CLABSI), and ventilator-associated pneumonia (VAP) using device days and bed days as the denominatorDESIGNRetrospective survey from October 2010 to July 2013SETTINGVeterans Health Administration medical centers providing acute medical and surgical carePATIENTSPatients admitted to 120 Veterans Health Administration medical centers reporting healthcare-associated infectionsMETHODSWe examined the importance of using device days and bed days as the denominator between infection rates and hospital rank for CAUTI, CLABSI, and VAP for each medical center. The relationship between device days and bed days as the denominator was assessed using a Pearson correlation, and changes in infection rates and device utilization were evaluated by an analysis of variance.RESULTSA total of 7.9 million bed days were included. From 2011 to 2013, CAUTI decreased whether measured by device days (2.32 to 1.64, P=.001) or bed days (4.21 to 3.02, P=.006). CLABSI decreased when measured by bed days (1.67 to 1.19, P=.04). VAP rates and device utilization ratios for CAUTI, CLABSI, and VAP were not statistically different across time. Infection rates calculated with device days were strongly correlated with infection rates calculated with bed days (r=0.79–0.94, P<.001). Hospital relative performance measured by ordered rank was also strongly correlated for both denominators (r=0.82–0.96, P<.001).CONCLUSIONSThese findings suggest that device days and bed days are equally effective adjustment metrics for comparing healthcare-associated infection rates between hospitals in the setting of stable device utilization.Infect Control Hosp Epidemiol 2015;00(0): 1–7


2016 ◽  
Vol 106 (2) ◽  
pp. 353-358 ◽  
Author(s):  
Marissa M. Maier ◽  
David B. Ross ◽  
Maggie Chartier ◽  
Pamela S. Belperio ◽  
Lisa I. Backus

Sign in / Sign up

Export Citation Format

Share Document